"Creatine Kinase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins.
| Descriptor ID |
D003402
|
| MeSH Number(s) |
D08.811.913.696.640.150
|
| Concept/Terms |
Creatine Kinase- Creatine Kinase
- Kinase, Creatine
- ATP Creatine Phosphotransferase
- Creatine Phosphotransferase, ATP
- Phosphotransferase, ATP Creatine
- Creatine Phosphokinase
- Phosphokinase, Creatine
- ADP Phosphocreatine Phosphotransferase
- Phosphocreatine Phosphotransferase, ADP
- Phosphotransferase, ADP Phosphocreatine
|
Below are MeSH descriptors whose meaning is more general than "Creatine Kinase".
Below are MeSH descriptors whose meaning is more specific than "Creatine Kinase".
This graph shows the total number of publications written about "Creatine Kinase" by people in this website by year, and whether "Creatine Kinase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Creatine Kinase" by people in Profiles.
-
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial. Lancet Gastroenterol Hepatol. 2022 03; 7(3):219-229.
-
Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America. Rheumatology (Oxford). 2021 04 06; 60(4):1839-1849.
-
Inflammation marker, damage marker and anabolic hormone responses to resistance training with vascular restriction in older males. Clin Physiol Funct Imaging. 2013 Sep; 33(5):393-9.
-
The effects of adding leucine to pre and postexercise carbohydrate beverages on acute muscle recovery from resistance training. J Strength Cond Res. 2010 Aug; 24(8):2211-9.
-
Effects of a protease supplement on eccentric exercise-induced markers of delayed-onset muscle soreness and muscle damage. J Strength Cond Res. 2007 Aug; 21(3):661-7.
-
The comparison and validity of troponin I assay systems in diagnosing myocardial ischemic injury after surgical coronary revascularization. J Cardiothorac Vasc Anesth. 2005 Jun; 19(3):288-93.
-
Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. J Cardiovasc Electrophysiol. 2002 Feb; 13(2):144-50.
-
Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies. Clin Diagn Lab Immunol. 1997 Sep; 4(5):519-21.
-
Diagnosis and treatment of polymyositis and dermatomyositis. Compr Ther. 1990 Apr; 16(4):16-24.
-
Laboratory manifestations of polymyositis/dermatomyositis. Clin Dermatol. 1988 Apr-Jun; 6(2):76-92.